SEARCH

SEARCH BY CITATION

References

  • Aldenkamp AP, Alpherts WCJ, Blennow G, Elmqvist D, Heijbel J, Nilsson HL, Sandstedt P, Tonnby B, Wahlander L, Wosse E. (1993) Withdrawal of antiepileptic medication in children – effects on cognitive function: the multicenter Holmfrid study. Neurology 43:4150.
  • Benton AL, Hamsher K. (1989) Multilingual Aphasia Examination. AJA Associates, Iowa City .
  • Callaghan N, Garrett A, Goggin T. (1988) Withdrawal of anticonvulsant drugs in patients free of seizures for two years. A prospective study. N Engl J Med 318;942946.
  • Chadwick D. (1999) Does withdrawal of different antiepileptic drugs have different effects on seizure recurrence? Further results from the MRC Antiepileptic Drug Withdrawal Study. Brain 122:441448.
  • Heaton RK, Grant I, Matthews CG. (1991) Comprehensive norms for an expanded Halsted-Reitan battery: demographic corrections, research findings, and clinical applications. Psychological Assessment Resources, Odessa , FL .
  • Hessen E, Lossius MI, Reinvang I, Gjerstad L. (2006) Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy. Epilepsia 47:20382045.
  • Hessen E, Lossius MI, Reinvang I, Gjerstad L. (2007) Influence of major antiepileptic drugs on neuropsychological function: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients on monotherapy. J Int Neuropsychol Soc 3:393400.
  • Jacoby A, Johnson A, Chadwick D. (1992) Psychosocial outcomes of antiepileptic drug discontinuation. The Medical Research Council Antiepileptic Drug Withdrawal Study Group. Epilepsia 33:11231131.
  • Kløve H. (1963) Clinical neuropsychology. In ForsterFM (Ed) The Medical Clinics of North America. Saunders, New York .
  • Kwan P, Brodie MJ. (2000) Early identification of refractory epilepsy. N Engl J Med 342:314319.
  • Lewis RF, Rennick PM. (1979) Manual for the Repeatable Cognitive-Perceptual-Motor Battery. Axon Publishing Co, Grosse Pointe Park , MI .
  • Meador KJ, Loring DW, Allen ME, Zamrini EY, Moore EE, Abney OL, King DW. (1991) Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 41:15371540.
  • Meador KJ, Loring DW, Abney OL, Allen ME, Moore EE, Zamrini EY, King DW. (1993) Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 34:153157.
  • Medical Research Council Antiepileptic Drug Withdrawal Study Group. (1991) Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet 337:11751180.
  • Medical Research Council Antiepileptic Drug Withdrawal Study Group. (1993) Prognostic index for recurrence after remission of epilepsy. BMJ 306:13741378.
  • Miller EN. (1990) California Computerized Assessment Battery (CalCAP) Manual. Norland Software, Los Angeles .
  • Overweg J, Binnie CD, Oosting J, Rowan AJ. (1987) Clinical and EEG prediction of seizure recurrence following antiepileptic drug withdrawal. Epilepsy Res 5:272283.
  • Prevey ML, Delaney RC, Cramer JA, Cattanach L, Collins JF, Mattson RH. (1996) Effect of valproate on cognitive functioning: comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. Arch Neurol 53:10081016.
  • Reitan RM, Wolfson D. (1985) The Halstead-Reitan Neuropsychological Test Battery. Neuropsychology Press, Tucson .
  • Rey A. (1964) L'examen clinique en psychologie. Presses Universitaires de France, Paris .
  • Schmidt M. (1996) Rey Auditory and Verbal Learning Test. A Handbook. Western Psychological Services, Los Angeles .
  • Sintonen H. (1994a) The 15D measures of health-related quality of life. I. Reliability, validity and sensitivity of its health state descriptive system. Working paper 41. National Centre for Health Program Evaluation. Melbourne , Australia .
  • Sintonen H. (1994b) The 15D measures of health-related quality of life. II. Feasibility, reliability and validity of its valuation system. Working paper 42. National Centre for Health Program Evaluation. Melbourne , Australia .
  • Specchio LM, Beghi E. (2004) Should antiepileptic drugs be withdrawn in seizure-free patients? CNS Drugs 18:201212.
  • Specchio LM, Tramacere L, La Neve A, Beghi E. (2002) Discontinuing antiepileptic drugs in patients who are seizure-free on monotherapy. J Neurol Neurosurg Psychiatry 72:2225.
  • Stavem K, Bjørnæs H, Lossius MI. (2000) Reliability and validity of a Norwegian version of the Quality of Life in Epilepsy Inventory (QOLIE-89) Epilepsia 41:9197.
  • Stavem K, Bjørnæs H, Lossius MI. (2001) Properties of the 15D and EQ-5D utility measures in a community sample of people with epilepsy. Epilepsy Res 44:179189.
  • The EuroQol Group. (1990) EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 16:199208.
  • Thompson P, Huppert F, Trimble M. (1980) Anticonvulsant drugs, cognitive function and memory. Acta Neurol Scand Suppl 80:7580.
  • Trenerry MR, Crosson B, DeBoe J, Leber WR. (1989) The Stroop Neuropsychological Screening Test. Psychological Assessment, Odessa , FL .
  • Vermeulen J, Aldenkamp AP. (1995) Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 22:6595.
  • Vickrey BG, Perrine KR, Hays RD, Herman BP, Cramer JA, Gordon J, Meador KJ, Devinsky O. (1993) Scoring Manual for the Quality of life in Epilepsy Inventory (QOLIE)-89. RAND, Santa Monica , California .
  • Wechsler D. (1987) Wechsler Memory Scale – Revised Manual. The Psychological Corporation, San Antonio .